CompletedNCT01183234
Official study titlePhase 1,Randomized,Open-Label,Two Period Single Dose Crossover Bioequivalence Study of Two Capsule Strengths of SPD544 In Healthy Volunteers.
This study has finished and is no longer accepting participants.
In LondonADHDMedication studyAges 18–55
- Countries
- United Kingdom
- Sponsor
- Shire
CompletedNCT03769064
Official study titlePhase 1, Single-dose, Double-blind, Rand., Placebo- and Active-controlled, 4-period, 4-sequence Crossover, Proof-of-Concept Study to Evaluate Effect of Naltrexone on Abuse Potential of Methylphenidate in Healthy Recreational Stimulant Users
This study has finished and is no longer accepting participants.
In Overland ParkADHDMedication studyAges 18–45
- Countries
- United States
- Sponsor
- Avekshan LLC
CompletedNCT00472511
Official study titleStudy of Eyes and Attention Deficit (SEAD)
This study has finished and is no longer accepting participants.
Location not clearly listedADHDObservational studyAges 7–18
- Countries
- Sponsor
- Ohio State University
CompletedNCT01108029
Official study titleStudy of Memantine to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Monocentric Trial
This study has finished and is no longer accepting participants.
In LilleADHDMedication studyAges 30–80
- Countries
- France
- Sponsor
- University Hospital, Lille
CompletedNCT00914095
Official study titleStudy of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial
This study has finished and is no longer accepting participants.
In LilleADHDMedication studyAges 30–80
- Countries
- France
- Sponsor
- University Hospital, Lille
CompletedNCT01924143
Official study titleAn Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects
This study has finished and is no longer accepting participants.
In LincolnADHDMedication studyAges 18–50
- Countries
- United States
- Sponsor
- Theravance Biopharma
CompletedNCT04278430
Official study titleDoes Transcranial Direct Current Stimulation Affect Selective Visual Attention in Children With Left-sided Infantile Hemiplegia? A Preliminary Randomized Controlled Study
This study has finished and is no longer accepting participants.
Location not clearly listedADHDDevice studyAges 8–15
- Countries
- Sponsor
- Majmaah University
CompletedNCT07486895
Official study titleAn Open-label, Randomized, Crossover Trial in Healthy Subjects to Assess Dose Strength Equivalence Among 164.4 and 328.8 mg Strengths of Oral Centanafadine QD XR Capsules
This study has finished and is no longer accepting participants.
In LenexaADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01993849
Official study titleA Randomized Placebo-controlled Trial of N-Acetylcysteine in Onychophagia
This study has finished and is no longer accepting participants.
In CharlestonADHDMedication studyAges 18–30
- Countries
- United States
- Sponsor
- Kevin Gray, MD
CompletedNCT02396576
This study has finished and is no longer accepting participants.
Multiple locations, including Canoga ParkADHD, Depression, ...Behavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedNCT03680885
Official study titleReliability Testing of a Non-invasive, Pain-free, Taste-based Assessment Approach to Lidocaine Effectiveness
This study has finished and is no longer accepting participants.
In The BronxADHDMedication studyAges 18–49
- Countries
- United States
- Sponsor
- PhenoSolve, LLC
CompletedNCT01621815
Official study titleVariance of Video Games Playing Patterns Among Adolescents With Psychiatric Disorders: Diagnostical and Dynamic Meanings
This study has finished and is no longer accepting participants.
In Hod HaSharonADHD, Depression, ...Behavioural studyAges 13–18
- Countries
- Israel
- Sponsor
- Shalvata Mental Health Center